India CDMO Market Size, Share, Trends and Forecast by Service Type, Type, Scale of Operation, Therapeutic Area, and Region, 2025-2033

India CDMO Market Size, Share, Trends and Forecast by Service Type, Type, Scale of Operation, Therapeutic Area, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A30719

India CDMO Market Overview:

The India CDMO market size reached USD 7.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.4 Billion by 2033, exhibiting a growth rate (CAGR) of 7.7% during 2025-2033. The market is experiencing robust growth, principally influenced by the increasing demand for contract manufacturing services in pharmaceuticals, particularly for complex generics, HPAPIs, and sterile injectables. With a strong regulatory framework and associated cost advantages, Indian CDMOs are expanding their global footprint, catering to markets like the U.S., Europe, and emerging economies, thereby creating a positive market outlook.

Report Attribute
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024 USD 7.9 Billion
Market Forecast in 2033 USD 15.4 Billion
Market Growth Rate 2025-2033 7.7%


India CDMO Market Trends:

Expansion of Biologics and Biosimilars Manufacturing

The contract development and manufacturing organization (CDMO) market in India is witnessing strong growth due to the rising demand for biologics and biosimilars. As global pharmaceutical companies increasingly outsource biologic drug development and production, Indian CDMOs are investing in advanced biomanufacturing capabilities, including mammalian and microbial expression systems. The push for affordable biosimilars is driving partnerships between firms, positioning India as a key hub for cost-effective, high-quality biologics production. For instance, in December 2024, Mankind Pharma Ltd announced a strategic partnership with Innovent Biologics to license and commercialize Sintilimab in India, aiming to improve cancer treatment access by providing innovative immunotherapy solutions to address critical healthcare challenges in the region. Additionally, the expansion of state-of-the-art bioreactors, single-use technologies, and process optimization strategies is enhancing efficiency and scalability in biopharmaceutical manufacturing. Regulatory alignment with agencies like USFDA and EMA further strengthens India’s competitive advantage in contract manufacturing. As the demand for targeted therapies, monoclonal antibodies, and gene-based treatments rises, Indian CDMOs are expected to play a critical role in supplying global markets, ensuring cost efficiency while maintaining high regulatory and quality standards.

India CDMO Market Size

Increasing Demand for End-to-End CDMO Services

Pharmaceutical companies are increasingly seeking end-to-end services from CDMOs, covering drug discovery, formulation development, clinical trial support, commercial-scale production, and regulatory compliance. This trend is driven by the need for faster time-to-market, cost-efficiency, and streamlined supply chains. Indian CDMOs are expanding their capabilities to offer comprehensive solutions, enabling global drug developers to outsource the entire product lifecycle under a single contract. The integration of AI-driven drug discovery, process automation, and real-time data analytics is further enhancing efficiency in development and manufacturing. Additionally, CDMOs are focusing on high-potency active pharmaceutical ingredients (HPAPIs), complex generics, and sterile injectables, strengthening their position as strategic outsourcing partners. For instance, in January 2024, Aragen Life Sciences announced a substantial investment of INR 20 Billion (approximately US$230.5 Million) in Telangana to bolster its drug discovery, development, and manufacturing capabilities, reflecting a strategic focus on expanding complex generics and HPAPI production. In addition, government incentives for pharmaceutical innovation, regulatory harmonization, and infrastructure development are supporting this growth. With increasing investments in R&D facilities, analytical services, and quality control, Indian CDMOs are emerging as preferred partners for global pharmaceutical companies seeking cost-effective, high-quality solutions.

India CDMO Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region level for 2025-2033. Our report has categorized the market based on service type, type, scale of operation, and therapeutic area.

Service Type Insights:

  • Contract Development Services
    • Preclinical Development
    • Clinical Development
    • Analytical and Bioanalytical Services
  • Contract Manufacturing Services
    • Active Pharmaceutical Ingredients (APIs) Manufacturing
    • Finished Dosage Forms (FDFs) Manufacturing
    • Biologics Manufacturing
    • Packaging

The report has provided a detailed breakup and analysis of the market based on the service type. This includes contract development services (preclinical development, clinical development, and analytical and bioanalytical services) and contract manufacturing services (active pharmaceutical ingredients (APIs) manufacturing, finished dosage forms (FDFs) manufacturing, biologics manufacturing, and packaging).

Type Insights:

India CDMO Market By Type

  • Small Molecules
  • Biologics
  • Biosimilars
  • Vaccines
  • Others

A detailed breakup and analysis of the market based on the type have also been provided in the report. This includes small molecules, biologics, biosimilars, vaccines, and others.

Scale of Operation Insights:

  • Commercial Scale
  • Clinical Scale

The report has provided a detailed breakup and analysis of the market based on the scale of operation. This includes commercial scale and clinical scale.

Therapeutic Area Insights:

  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Central Nervous System (CNS) Disorders
  • Others

A detailed breakup and analysis of the market based on the therapeutic area have also been provided in the report. This includes oncology, cardiovascular diseases, infectious diseases, central nervous system (CNS) disorders, and others.

Regional Insights:

  • North India
  • South India
  • East India
  • West India

The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

India CDMO Market News:

  • In December 2024, Akums Drugs and Pharmaceuticals Limited announced a partnership with a notable global pharma company to serve as a CDMO, manufacturing and supplying oral liquid formulations for the European market. The agreement, valued at Euro 200 million, will begin in 2027, with approvals anticipated by 2026.

India CDMO Market Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Service Type
  • Type
  • Scale of Operation
  • Therapeutic Area 
  • Region
Service Types Covered
  • Contract Development Services: Preclinical Development, Clinical Development, Analytical and Bioanalytical Services
  • Contract Manufacturing Services: Active Pharmaceutical Ingredients (APIs) Manufacturing, Finished Dosage Forms (FDFs) Manufacturing, Biologics Manufacturing, Packaging
Types Covered Small Molecules, Biologics, Biosimilars, Vaccines, Others
Scale of Operations Covered Commercial Scale, Clinical Scale
Therapeutic Areas Covered Oncology, Cardiovascular Diseases, Infectious Diseases, Central Nervous System (CNS) Disorders, Others
Regions Covered North India, South India, East India, West India
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the India CDMO market performed so far and how will it perform in the coming years?
  • What is the breakup of the India CDMO market on the basis of service type?
  • What is the breakup of the India CDMO market on the basis of type?
  • What is the breakup of the India CDMO market on the basis of scale of operation?
  • What is the breakup of the India CDMO market on the basis of therapeutic area?
  • What is the breakup of the India CDMO market on the basis of region?
  • What are the various stages in the value chain of the India CDMO market? 
  • What are the key driving factors and challenges in the India CDMO market?
  • What is the structure of the India CDMO market and who are the key players?
  • What is the degree of competition in the India CDMO market? 

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India CDMO market from 2019-2033.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the India CDMO market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India CDMO industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
India CDMO Market Size, Share, Trends and Forecast by Service Type, Type, Scale of Operation, Therapeutic Area, and Region, 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials